Clinical trial
Bisphosphonate Therapy for Osteogenesis Imperfecta
NCT00159419 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00159419 |
|---|---|
| Title | Bisphosphonate Therapy for Osteogenesis Imperfecta |
| Official title | Bisphosphonate Therapy for Osteogenesis Imperfecta |
| Lead sponsor | Indiana University School of Medicine, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteogenesis Imperfecta, Osteoporosis, Paget Disease of Bone |
| Intervention type | Drug |
| Interventions | Alendronate, Pamidronate |
| Enrollment | 18 |
| Start date | Aug 1, 1999 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 14, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: